Infantile cardioencephalopathy due to a COX15 gene defect: report and review

Majid Alfadhel1, Yolanda P Lillquist, Paula J Waters

  • 1Department of Paediatrics, Children's and Women's Health Centre, Vancouver, British Columbia, Canada.

Insights

Respiratory chain complex IV deficiency, a severe condition, was identified in an infant with microcephaly and cardiomyopathy. Genetic analysis revealed mutations in the COX15 gene, impacting cardiac muscle function.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatric Medicine

Background:

  • Respiratory chain complex IV (cytochrome c oxidase) is crucial for cellular energy production.
  • Deficiency in complex IV can lead to severe, multi-systemic disorders.
  • Neonatal onset of complex IV deficiency often presents with a rapidly progressive and fatal course.

Observation:

  • A female infant presented with microcephaly, encephalopathy, persistent lactic acidosis, and hypertrophic cardiomyopathy.
  • The clinical course was rapidly progressive and fatal within the neonatal period.
  • Postmortem examination revealed marked complex IV deficiency specifically in cardiac muscle.

Findings:

  • Complex IV activity was significantly reduced in the heart but only slightly decreased in skeletal muscle.
  • Molecular investigations identified compound heterozygosity for two pathogenic mutations in the COX15 gene.
  • This genetic profile explains the tissue-specific severity of the deficiency.

Implications:

  • This case highlights the critical role of COX15 in cardiac function and development.
  • Understanding genotype-phenotype correlations in COX15-related complex IV deficiency is essential for diagnosis.
  • Further research into COX15 mutations can inform potential therapeutic strategies for mitochondrial disorders.

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...